WHO grade I and II meningiomas had 16 antigens in common with three antigens exclusively presented by WHO grade I meningiomas (TC1D2, B4GALT4, and MTU1) (Supplementary Table 5, online resource 1). This evidence concerns the gene B4GALT4 and meningioma.